Evaluation of the Endorsement of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement on the Quality of Published Systematic Review and Meta-Analyses
By N. Panic, E. Leoncini, Giulio de Belvis, W. Ricciardi, S. Boccia. PLoS ONE, 2013
810 citations recorded by the source corpus.
Introduction PRISMA statement was published in 2009 in order to set standards in the reporting of systematic reviews and meta-analyses. Our aim was to evaluate the impact of PRISMA endorsement on the quality of reporting and methodological quality of systematic reviews and meta-analyses, published in journals in the field of gastroenterology and hepatology (GH). Methods Quality of reporting and methodological quality were evaluated by assessing the adherence of papers to PRISMA checklist and AMSTAR quality scale. After identifying the GH journals which endorsed PRISMA in instructions for authors (IA), we appraised: 15 papers published in 2012 explicitly mentioning PRISMA in the full text (Group A); 15 papers from the same journals published in 2012 not explicitly mentioning PRISMA in the full text (Group B); 30 papers published the year preceding PRISMA endorsement from the same journals as above (Group C); 30 papers published in 2012 on the 10 highest impact factor journals in GH which not endorsed PRISMA (Group D). Results PRISMA statement was referred in the IA in 9 out of 70 GH journals (12.9%). We found significant increase in overall adherence to PRISMA checklist (Group A, 90.1%; Group C, 83.1%; p = 0.003) and compliance to AMSTAR scale (Group A, 85.0%; Group C, 74.6%; p = 0.002), following the PRISMA endorsement from the nine GH journals. Explicit referencing of PRISMA in manuscript was not associated with increase in quality of reporting and methodological quality (Group A vs. B, p = 0.651, p = 0.900, respectively). Adherence to PRISMA checklist, and the compliance with AMSTAR were significantly higher in journals endorsing PRISMA compared to those not (Groups A+B vs. D; p = 0.003 and p = 0.016, respectively). Conclusion The endorsement of PRISMA resulted in increase of both quality of reporting and methodological quality. It is advised that an increasing number of medical journals include PRISMA in the instructions for authors.
Subfields: Safety Research, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/df75cf48dc55fbc99073132e892e39d34a1e1731
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Safety Research
In Statistics and Probability
- David Moher
- Matthew J. Page
- Larissa Shamseer
- I. Boutron
- J. Yepes‐Nuñez
- G. Úrrutia
- Marta Romero-García
- S. Alonso-Fernández
Citations in the corpus
- Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (2017, methodology): “Association between journal endorsement of the PRISMA Statement and SR adherence to PRISMA [38, 39, 46, 71, 77, 81, 84, 94] 8”
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews (2021, background): “They include educators introducing reporting guidelines into graduate curricula to promote good reporting habits of early career scientists [65]; journal editors and regulators endorsing use of reporting guidelines [18]; peer reviewers evaluating adherence to reporting guidelines [61, 66]; journals ”
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. (2021, background): “They include educators introducing reporting guidelines into graduate curricula to promote good reporting habits of early career scientists [65] ; journal editors and regulators endorsing use of reporting guidelines [18] ; peer reviewers evaluating adherence to reporting guidelines [61 , 66] ; journ”